目次

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key secondary sources
2.1.1.2 List of key secondary sources
2.1.1.3 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key objectives of primary research
2.1.2.2 List of primary sources
2.1.2.3 Key data from primary sources
2.1.2.4 Breakdown of primary interviews
2.1.2.5 Insights from industry experts
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Revenue estimation of key players
2.2.1.2 Annual reports and investor presentations
2.2.1.3 Primary interviews
2.2.1.4 Growth forecast
2.2.1.5 CAGR projections
2.2.2 TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.4.1 PARAMETRIC ASSUMPTIONS
2.4.2 GROWTH RATE ASSUMPTIONS
2.4.3 SCOPE-RELATED ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN UROLOGY DEVICES MARKET
4.2 ASIA PACIFIC UROLOGY DEVICES MARKET, BY END USER AND COUNTRY
4.3 UROLOGY DEVICES MARKET, BY COUNTRY
4.4 UROLOGY DEVICES MARKET, BY REGION

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising incidence of urological diseases
5.2.1.2 Growing preference for minimally invasive procedures
5.2.1.3 Technological advancements and increased R&D investments
5.2.1.4 Increasing number of hospitals and surgical centers
5.2.2 RESTRAINTS
5.2.2.1 High degree of consolidation among key players
5.2.3 OPPORTUNITIES
5.2.3.1 Potential growth opportunities in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Increasing number of product recalls by key players
5.2.4.2 Shortage of urologists and trained professionals
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE TREND, BY TYPE
5.4.2 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
5.4.3 AVERAGE SELLING PRICE TREND, BY REGION
5.5 VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
5.8 INVESTMENT AND FUNDING SCENARIO
5.9 TECHNOLOGY ANALYSIS
5.9.1 KEY TECHNOLOGIES
5.9.1.1 Antimicrobial-coated catheters
5.9.1.2 Portable hemodialysis
5.9.2 COMPLEMENTARY TECHNOLOGIES
5.9.2.1 Smart catheters
5.9.2.2 Connected health & remote sensors
5.9.3 ADJACENT TECHNOLOGIES
5.9.3.1 Wearable artificial kidney
5.10 PATENT ANALYSIS
5.11 TRADE ANALYSIS
5.11.1 IMPORT DATA FOR HS CODE 841920
5.11.2 EXPORT DATA FOR HS CODE 841920
5.12 KEY CONFERENCES AND EVENTS, 2025-2026
5.13 REGULATORY ANALYSIS
5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.13.2 REGULATORY FRAMEWORK
5.13.2.1 North America
5.13.2.1.1 US
5.13.2.1.2 Canada
5.13.2.2 Europe
5.13.2.3 Asia Pacific
5.13.2.3.1 China
5.13.2.3.2 Japan
5.13.2.3.3 India
5.13.2.4 Latin America
5.13.2.4.1 Brazil
5.13.2.4.2 Mexico
5.13.2.5 Middle East
5.13.2.6 Africa
5.14 PORTER’S FIVE FORCES ANALYSIS
5.14.1 BARGAINING POWER OF SUPPLIERS
5.14.2 BARGAINING POWER OF BUYERS
5.14.3 THREAT OF NEW ENTRANTS
5.14.4 THREAT OF SUBSTITUTES
5.14.5 INTENSITY OF COMPETITIVE RIVALRY
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.15.2 KEY BUYING CRITERIA
5.16 IMPACT OF AI/GEN AI ON UROLOGY DEVICES MARKET
5.16.1 INTRODUCTION
5.16.2 POTENTIAL OF AI
5.16.3 IMPACT OF AI
5.16.4 KEY COMPANIES IMPLEMENTING AI
5.16.5 FUTURE OF AI
5.17 IMPACT OF 2025 US TARIFF ON UROLOGY DEVICES MARKET
5.17.1 INTRODUCTION
5.17.2 KEY TARIFF RATES
5.17.3 PRICE IMPACT ANALYSIS
5.17.4 IMPACT ON COUNTRY/REGION
5.17.4.1 North America
5.17.4.2 Europe
5.17.4.3 Asia Pacific
5.17.5 IMPACT ON END-USE INDUSTRIES
5.17.5.1 Hospitals
5.17.5.2 Clinics
5.17.5.3 Ambulatory Surgical Centers (ASCs)
5.17.5.4 Dialysis centers
5.17.5.5 Home care settings

6 UROLOGY DEVICES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 INSTRUMENTS
6.2.1 DIALYSIS DEVICES
6.2.1.1 Hemodialysis devices
6.2.1.1.1 Increasing use of dialysis machines to spur growth
6.2.1.2 Peritoneal dialysis devices
6.2.1.2.1 Rising technological advancements and increasing product approvals to propel market
6.2.2 ENDOSCOPES
6.2.2.1 Laparoscopes
6.2.2.1.1 Lower surgical site infections to support growth
6.2.2.2 Ureteroscopes
6.2.2.2.1 Increased usage of ureteroscopy for kidney stones to drive market
6.2.2.3 Nephroscopes
6.2.2.3.1 High cost of maintenance to restrain market growth
6.2.2.4 Resectoscopes
6.2.2.4.1 High prevalence of prostate, kidney, and bladder cancers to fuel market
6.2.2.5 Cystoscopes
6.2.2.5.1 Growing incidence of urological cancers to boost market
6.2.3 LASER & LITHOTRIPSY DEVICES
6.2.3.1 Associated benefits of lithotripsy devices to support growth
6.2.4 ENDOVISION & IMAGING SYSTEMS
6.2.4.1 Need for high-resolution images to aid growth
6.2.5 ROBOTIC SYSTEMS
6.2.5.1 Growing industry-academia collaborations to fuel market
6.2.6 INSUFFLATORS
6.2.6.1 Increasing volume of laparoscopic procedures to boost market
6.2.7 ENDOSCOPY FLUID MANAGEMENT SYSTEMS
6.2.7.1 Growing incidence of chronic diseases to drive market
6.2.8 URODYNAMIC SYSTEMS
6.2.8.1 Rising patient pool to support growth
6.2.9 OTHER INSTRUMENTS
6.3 CONSUMABLES & ACCESSORIES
6.3.1 DIALYSIS CONSUMABLES
6.3.1.1 Growing number of dialysis procedures to fuel market
6.3.2 CATHETERS
6.3.2.1 Intermittent catheters
6.3.2.1.1 Rising clinical adoption of intermittent catheters to support growth
6.3.2.2 Indwelling catheters
6.3.2.2.1 Increased use in hospitals and home care settings to facilitate growth
6.3.2.3 External catheters
6.3.2.3.1 Growing preference for home-based management of chronic urinary conditions to drive market
6.3.3 GUIDEWIRES
6.3.3.1 Increasing number of surgeries and development of next-generation hybrid guidewires to drive market
6.3.4 RETRIEVAL DEVICES & EXTRACTORS
6.3.4.1 Growing number of kidney stone removal surgeries to fuel market
6.3.5 SURGICAL DISSECTORS, FORCEPS & NEEDLE HOLDERS
6.3.5.1 Rise in urology procedures to support growth
6.3.6 DILATOR SETS & URETHRAL ACCESS SHEATHS
6.3.6.1 Increasing demand for effective endoscopic management of ureteral and renal calculi to aid growth
6.3.7 STENTS & IMPLANTS
6.3.7.1 Growing prevalence of urological, kidney-related disorders, and erectile dysfunction to propel market
6.3.8 BIOPSY DEVICES
6.3.8.1 High incidence of prostate cancer to contribute to growth
6.3.9 TUBES & DISTAL ATTACHMENTS
6.3.9.1 Increasing demand for endoscopy to boost market
6.3.10 DRAINAGE BAGS
6.3.10.1 Increasing prevalence of urinary incontinence and chronic kidney disease to foster growth
6.3.11 OTHER CONSUMABLES & ACCESSORIES

7 UROLOGY DEVICE MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 KIDNEY DISEASES
7.2.1 GROWING PREVALENCE OF DIABETES AND HYPERTENSION TO DRIVE MARKET
7.3 UROLOGICAL CANCER
7.3.1 RISING PREVALENCE OF UROLOGICAL CANCER TO CONTRIBUTE TO GROWTH
7.4 PELVIC ORGAN PROLAPSE
7.4.1 HIGH COSTS INVOLVED IN SURGERIES & HIGH REOCCURRENCE RATES TO RESTRAIN GROWTH
7.5 BENIGN PROSTATIC HYPERPLASIA (BPH)
7.5.1 INCREASING ELDERLY POPULATION TO AID GROWTH
7.6 URINARY INCONTINENCE (UI)
7.6.1 NEED FOR PROPER DIAGNOSIS AND TREATMENT TO SUPPORT GROWTH
7.7 ERECTILE DYSFUNCTION
7.7.1 INCREASING PREVALENCE OF PROSTATE CANCER TO AID GROWTH
7.8 URINARY STONES
7.8.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO FUEL MARKET
7.9 OTHER APPLICATIONS

8 UROLOGY DEVICES MARKET - EPIDEMIOLOGY AND PREVALENCE ANALYSIS, 2023-2030 (NO. OF CASES/PREVALENCE)

9 UROLOGY DEVICES MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS
9.2.1 INCREASING NUMBER OF HOSPITALS IN EMERGING ECONOMIES TO EXPEDITE GROWTH
9.3 AMBULATORY SURGERY CENTERS
9.3.1 LOWER COST AND SHORTER PATIENT STAYS TO PROMOTE GROWTH
9.4 CLINICS
9.4.1 GROWING INTEGRATION OF ADVANCED TECHNOLOGY IN UROLOGY CLINICS TO PROPEL MARKET
9.5 DIALYSIS CENTERS
9.5.1 RISING DEMAND FOR ADVANCED DIALYSIS AND END-STAGE RENAL DISEASE TREATMENTS TO AID GROWTH
9.6 HOME CARE SETTINGS
9.6.1 LOWER COST AND SHORTER HOSPITAL STAYS TO BOOST MARKET

10 UROLOGY DEVICES MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 Presence of large dialysis patient base and robust infrastructure to promote growth
10.2.3 CANADA
10.2.3.1 Increasing focus on preventing target diseases to expedite growth
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Presence of major urology device manufacturers to contribute to growth
10.3.3 UK
10.3.3.1 Rising incidence of kidney conditions to bolster growth
10.3.4 FRANCE
10.3.4.1 Favorable government initiatives and shifting demographic trends to aid growth
10.3.5 ITALY
10.3.5.1 Increasing cases of chronic diseases to spur growth
10.3.6 SPAIN
10.3.6.1 Rising geriatric population to accelerate growth
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK
10.4.2 CHINA
10.4.2.1 Rising incidence of target health conditions and decreasing mortality rate to facilitate growth
10.4.3 JAPAN
10.4.3.1 Large geriatric population and established healthcare system to support growth
10.4.4 INDIA
10.4.4.1 Large patient pool and rapidly growing healthcare sector to drive market
10.4.5 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK
10.5.2 BRAZIL
10.5.2.1 Rising cases of metabolic diseases to support growth
10.5.3 MEXICO
10.5.3.1 Increasing prevalence of diabetes and kidney disorders to expedite growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022-2025
11.3 REVENUE ANALYSIS, 2022-2024
11.4 MARKET SHARE ANALYSIS, 2024
11.5 COMPANY VALUATION AND FINANCIAL METRICS
11.6 BRAND/PRODUCT COMPARISON
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.7.1 STARS
11.7.2 EMERGING LEADERS
11.7.3 PERVASIVE PLAYERS
11.7.4 PARTICIPANTS
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.7.5.1 Company footprint
11.7.5.2 Region footprint
11.7.5.3 Product footprint
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
11.8.1 PROGRESSIVE COMPANIES
11.8.2 RESPONSIVE COMPANIES
11.8.3 DYNAMIC COMPANIES
11.8.4 STARTING BLOCKS
11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
11.8.5.1 Detailed list of key startups/SMEs
11.8.5.2 Competitive benchmarking of key startups/SMEs
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES AND APPROVALS
11.9.2 DEALS
11.9.3 EXPANSIONS

12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 FRESENIUS MEDICAL CARE AG & CO. KGAA
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Deals
12.1.1.3.2 Expansions
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses and competitive threats
12.1.2 BOSTON SCIENTIFIC CORPORATION
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Product launches and approvals
12.1.2.3.2 Deals
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 B. BRAUN MELSUNGEN AG
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Deals
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses and competitive threats
12.1.4 BECTON, DICKINSON AND COMPANY
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 MnM view
12.1.4.3.1 Key strengths
12.1.4.3.2 Strategic choices
12.1.4.3.3 Weaknesses and competitive threats
12.1.5 OLYMPUS CORPORATION
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.3.1 Product launches and approvals
12.1.5.3.2 Deals
12.1.5.3.3 Expansions
12.1.6 CARDINAL HEALTH
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 Recent developments
12.1.6.3.1 Deals
12.1.7 INTUITIVE SURGICAL
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.7.3 Recent developments
12.1.7.3.1 Product launches and approvals
12.1.8 COLOPLAST A/S
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.8.3 Recent developments
12.1.8.3.1 Product launches and approvals
12.1.9 STRYKER
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.9.3 Recent developments
12.1.9.3.1 Product launches and approvals
12.1.10 TELEFLEX INCORPORATED
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.10.3 Recent developments
12.1.10.3.1 Product launches and approvals
12.1.11 CONVATEC GROUP PLC
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.12 MEDTRONIC PLC
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.12.3 Recent developments
12.1.12.3.1 Expansions
12.2 OTHER PLAYERS
12.2.1 KARL STORZ
12.2.2 COOK MEDICAL
12.2.3 RICHARD WOLF GMBH
12.2.4 COMPACTCATH
12.2.5 DORNIER MEDTECH
12.2.6 NIKKISO CO., LTD.
12.2.7 DIALIFE SA
12.2.8 ERBE VISION
12.2.9 WELL LEAD MEDICAL CO., LTD.
12.2.10 ROCAMED
12.2.11 ENDOMED SYSTEMS GMBH
12.2.12 AMSINO INTERNATIONAL, INC.
12.2.13 MEDISPEC
12.2.14 VIMEX SP. Z O. O.
12.2.15 BALTON SP. Z O.O.
12.2.16 HUNTER UROLOGY
12.2.17 RIBBEL INTERNATIONAL LIMITED

13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS